This formulation combines Tesamorelin, a synthetic analog of growth hormonereleasing hormone (GHRH), and Ipamorelin, a selective growth hormone secretagogue, both of which are commonly examined in laboratory environments for their influence on endocrine signaling pathways related to growth hormone regulation
Natl Cancer Inst 71, 473479 (1983)
When researchers reference all four compounds together, its typically because each represents a different node in metabolic and growth-hormone research: AOD-9604 for its fragment-based lipid pathway, MOTS-c for mitochondrial signaling, Tesamorelin for GHRH receptor stimulation, and Ipamorelin for ghrelin receptor-mediated growth hormone release
2017 Analysis of KPV and GHK-Cu regarding nuclear factor-B (NF-B) and TNF- signaling pathway interactions
Our expertise in bulk production, third-party manufacturing, and private label services positions us as a preferred pharmaceutical manufacturing partner globally